Le Lézard
Classified in: Health
Subjects: PDT, TDS, VET

Signia Showcases Advanced Xperience Hearing Aid & Tinnitus Solutions for Veterans at JDVAC 2021


PISCATAWAY, N.J., Feb. 24, 2021 /PRNewswire/ -- Hearing aid innovator Signia today announced it will showcase its industry-leading Xperience hearing aids and tinnitus solutions at JDVAC 2021 that enable veterans to enhance their human performance through improved hearing in every situation.

JDVAC, the Joint Defense Veterans Audiology Conference, is produced annually by the Association of VA Audiologists (AVAA) and the Military Audiology Association (MAA) and is taking place virtually this year from March 1-3. Signia will be exhibiting at a virtual booth and will spotlight its latest Signia Xperience hearing aids offered to veterans through the US Department of Veterans Affairs (VA) and to active military through the Department of Defense (DoD), including its Pure Charge&Go X, Pure 312 X, Styletto X and CROS X hearing aids. 

"Each year, JDVAC provides us with a terrific opportunity to connect with the VA audiologist community and highlight the latest Signia innovations that are enabling our veterans to live their best lives through optimized hearing in any situation," stated John Murray, Signia's Vice President of Government Services. "Whether it's sound amplification, improved speech intelligibility or tinnitus therapy, Signia delivers some of the most iconic innovations in the hearing aid market, helping VA and DoD audiologists to give veterans and active military an edge through enhanced hearing performance."

Throughout the conference, Signia staff will engage with attendees and be available to answer any questions about Signia solutions. Signia will also showcase a 15-minute video CEU outlining current Signia products and benefits, in addition to a variety of downloadable, educational content to provide attendees with useful product information alongside research and whitepapers on how these solutions can help veterans with hearing loss.

In addition to the exhibition, Dr. Gus Mueller, a luminary in the industry and Signia advisor, and Dr. Carol Meyers, Manager, Clinical Education at Signia, will lead an informative session on the latest solutions from Signia, helping attendees discover how connectivity, core signal processing and personalization provide practical and significant benefits to veteran patients in their everyday activities. The presentation, titled "Distinctive Innovations from Signia," will take place on Wednesday, March 3 at 9:30am CST.

Signia Xperience hearing aids showcased at JDVAC are backed by multiple audiology and technology world firsts, such as acoustic-motion sensors, Own Voice Processing (OVPtm), the Signia app, and more. These innovations are designed to combat stigma, drive adoption, and ultimately enable veterans to optimize their human performance through enhanced hearing. Conference attendees can expect to see the following innovations from Signia at JDVAC 2021:

For more information on Signia's VA market hearing aid solutions, click here. For hi-res photography, click here

About Signia

Signia is one of the world's leading hearing aid brands. We aim to enhance human performance through iconic innovations and consumer-friendly designs that shape the hearing health market. Since its launch in 2016, Signia has regularly brought world-first hearing solutions to the market and is a pioneer in rechargeable hearing technology. 

In addition to highly innovative hearing aids, Signia also delivers tools and apps to increase customer interaction and engagement at all levels of hearing aid management. Signia, and its hearing care professionals, enable hearing aid wearers to not just correct hearing loss but to gain an edge ? to Be Brilliant. 

Contact for journalists:
Daniel Griffin
[email protected]
Phone: +1.845.536.2200

 

SOURCE Signia


These press releases may also interest you

at 13:15
"I'm a nurse and I thought there could be a better way to apply Epsom salt to help relieve pain and inflammation," said an inventor, from Charlotte, N.C., "so I invented the INFLAMMATION BE- GONE PAD. My design can easily and neatly be applied to the...

at 13:15
The Bufford Family Office is excited to announce the acquisition of The Vanguard Academy in Norton Commons. Following the recent announcement of a new school to be built on O'Bannon Station Way, the Norton Commons property will launch as the first...

at 13:10
Wormington & Bollinger is actively reviewing product liability cases associated with antibiotic eyedrops causing Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). AbbVie, Inc. , a pharmaceutical company headquartered in Chicago,...

at 13:05
Genesis PDPA (Placentally Derived Protein Arrays) is a groundbreaking product that represents the culmination of cutting-edge research in developmental biology and harnessing the power of messaging cell factors. These PDPA cell factors are believed...

at 12:53
Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Regeneron Pharmaceuticals, Inc. breached their fiduciary duties to shareholders. The investigation concerns potential...

at 12:30
CSI Companies is excited to announce the appointment of Douglas Herr as Senior Vice President of Client Services and Strategy. With over 25 years of experience in healthcare, Douglas...



News published on and distributed by: